Cagri
SKU：cagri
Price：USD 70.00
Product information
Cagri is a long-acting analog of amylin, a hormone released with insulin by pancreatic beta cells. Research examines amylin and calcitonin receptors, satiety signalling, food intake and gastric emptying. An attached fatty-acid chain is associated with albumin binding. These are experimental characteristics and research endpoints, not an established treatment claim for this material.
Product specifications
- Compound Class
- Long-acting amylin analogue
- Research Name
- Cagri
- Target
- Amylin receptors (AMY1-3) and calcitonin receptor (CTR)
- Form
- Lyophilized powder
- Molecular Weight
- 4,409 g/mol
- Purity
- ≥99% (HPLC verified)
- Testing
- Third-party HPLC, Mass Spec, Endotoxin
- Half-Life
- ~7 days
- Storage
- -20°C for long-term stability
- Solubility
- Water-soluble
- Label amount
- 10mg
Analysis report
Cagri 10mg · 10mg · R56A0B
Research information
Read the full Cagri research monograph
Research overview
Cagri is a long-acting analog of amylin, a hormone released with insulin by pancreatic beta cells. Research examines amylin and calcitonin receptors, satiety signalling, food intake and gastric emptying. An attached fatty-acid chain is associated with albumin binding. These are experimental characteristics and research endpoints, not an established treatment claim for this material.